双期分流注射方案用于常规增强胸部CT:与传统早期单期注射技术的比较
回顾性纳入202例患者,比较传统早期单期团注(A组102例)与双期分流团注(B组100例)常规增强胸部CT;两组胸部大血管强化无显著差异,B组胸膜、肝实质及门静脉强化显著更高且血管周围伪影更少。
要点
- 分流团注方案单次采集可同时获得早期与延迟期图像,血管与软组织均强化。
- B组胸膜、肝实质、门静脉强化及肝CNR显著高于A组,胸部大血管强化无显著差异。
- B组血管周围伪影更少,纵隔淋巴结评估优于A组。
核心结论
- 分流团注胸部CT注射方案可同时实现血管结构与软组织强化,可能提高诊断信心而无需多次采集。
- 作者认为该方案可能成为肺癌分期中有指征行胸腹部联合增强CT时的一种有前景的替代方案,并建议进一步评估其在该场景中的诊断效用,尤其是与延迟期胸上腹部CT方案比较。
研究设计与样本
- 回顾性纳入202例接受常规增强胸部CT的患者,A组102例采用传统早期单期团注技术,B组100例采用双期分流团注方案。
- 由两名放射科医师独立在纵隔窗上以圆形ROI测量主肺动脉分叉层面主肺动脉、主肺动脉分叉层面胸主动脉、肝门部门静脉、左右肝叶及增厚胸膜(>2 mm)的强化值并计算归一化强化值。
- 对对比剂相关伪影进行分级,并对纵隔淋巴结进行定性评估;测量背景噪声并计算肝脏及胸主动脉的对比噪声比。
关键影像表现/征象
- A组与B组胸部血管强化及归一化主肺动脉强化无显著差异(p > 0.05)。
- B组胸膜、肝实质及门静脉强化与归一化强化均显著高于A组(p < 0.001)。
- 限制评估的血管周围伪影B组少于A组;纵隔淋巴结评估A组判为差于B组,两名观察者间一致性极好。
- 胸主动脉CNR两组无显著差异(p = 0.633),肝脏CNR B组高于A组(p < 0.001)。
临床应用与阅片要点
- 分流团注方案可在单次采集中获得胸部血管与肝实质、门静脉及胸膜的同时强化,阅片时需注意其强化时相与常规早期单期图像不同。
- 作者建议进一步评估该方案在肺癌分期胸腹部联合增强CT中的诊断效用,尤其是与延迟期胸上腹部CT方案比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To present a routine contrast-enhanced chest CT protocol with a split-bolus injection technique achieving combined early- and delayed phase images with a single aquisition, and to compare this technique with a conventional early-phase single-bolus chest CT protocol we formerly used at our institution, in terms of attenuation of great thoracic vessels, pleura, included hepatic and portal venous enhancement, contrast-related artifacts, and image quality.
METHODS: A total of 202 patients, who underwent routine contrast-enhanced chest CT examination aquired with either conventional early-phase single-bolus technique (group A,n = 102) or biphasic split-bolus protocol (group B,n = 100), were retrospectively included. Attenuation measurements were made by two radiologists independently on mediastinal window settings using a circular ROI at the following sites: main pulmonary artery (PA) at its bifurcation level, thoracal aorta (TA) at the level of MPA bifurcation,portal vein (PV) at porta hepatis, left and right hepatic lobe, and if present, thickened pleura (>2 mm) at the level with the most intense enhancement. Respective normalized enhancement values were also calculated. Contrast-related artifacts were graded and qualitative evaluation of mediastinal lymph nodes was performed by both reviewers independently. Background noise was measured and contrast-to-noise ratios (CNRs) of the liver and TA were calculated.
RESULTS: While enhancement of thoracic vessels and normalised MPA enhancement did not differ significantly between both groups (p > 0.05), enhancement and normalised enhancement of pleura, liver parenchyma and PV was significantly greater in group B (p < 0.001). Perivenous artifacts limiting evaluation were less frequent in group B than in A and mediastinal lymph nodes were judged to be evaluated worse in group A than in group B with an excellent agreement between both observers. No significant difference was detected in CNRTA (p = 0.633), whereas CNR liver was higher in group B (p < 0.001).
CONCLUSION: Our split-bolus chest CT injection protocol enables simultaneous enhancement for both vascular structures and soft tissues, and thus, might raise diagnostic confidence without the need of multiple acquisitions.
ADVANCES IN KNOWLEDGE: We think that this CT protocol might also be a promising alternative in lung cancer staging, where combined contrast-enhanced CT of the chest and abdomen is indicated. We therefore suggest to further evaluate its diagnostic utility in this setting, in particular in comparison with a late delayed chest-upper abdominal CT imaging protocol.
引用
- Kul, Kuru Öz, Gürsoy Coruh, et al. Biphasic split-bolus injection protocol for routine contrast-enhanced chest CT: comparison with conventional early-phase single bolus technique. Br J Radiol. 2022. PMID: 35171718. doi:10.1259/bjr.20210775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。